Unstandardized combination

KLOW

KPV + GHK-Cu + BPC-157 + TB-500

Uncertain or Concerning
Identity

Commercial or common name

KLOW. This name is not standardized.

Variants

Reported formulation variants

  • No authoritative formulation specification
Combination evidence

What the combination shows

No adequate human combination evidence was identified in the static MVP review. Component-level findings do not transfer to the combination.

Regulatory

Status

Unapproved / RUO. No approval is implied by use of a commercial or community name.

Human research

Combination trial status

No validated human combination trial identified

Quality

Stability and compatibility

Compatibility, sterility and stability are not established across marketed variants

Claims

Common marketing claims

  • Inflammation control
  • Skin and gut support
Evidence-based conclusion

Bottom line

This named stack should be evaluated as an unstandardized combination. It does not inherit the evidence score of its strongest component.

Individual component evidence

Experimental / RUOAugust 5, 2026

KPV

Lys-Pro-Val

Inflammation claims · Skin and gut claims

Tier 3Unapproved / RUO
Cosmetic / TopicalAugust 5, 2026

GHK-Cu

Copper peptide

Cosmetic skin care · Hair-care claims

Tier 3Cosmetic
Experimental / RUOAugust 5, 2026

BPC-157

Body protection compound 157

Recovery claims · Gastrointestinal claims

Tier 3Unapproved / RUO
Experimental / RUOAugust 5, 2026

TB-500

Thymosin beta-4 fragment

Recovery claims · Wound-healing claims

Tier 3Unapproved / RUO